Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
Related Keywords
, Cyclo Therapeutics Company Profile , Northern Trust Corp , Cyclo Therapeutics Inc , Armistice Capital , Maxim Group , Vanguard Group Inc , Renaissance Technologies , Nasdaq , Geode Capital Management , Cyclo Therapeutics , Get Free Report , Trust Corp , Capital Management , Trappsol Cyclo , Cyclo Therapeutics Daily , Nasdaq Cyth , Scyth , Medical , Stocks , Options , Put , Call ,
comparemela.com © 2020. All Rights Reserved.